Vedano al Lambro, Italy

Barbara Salom


 

 

Average Co-Inventor Count = 5.9

ph-index = 7

Forward Citations = 156(Granted Patents)


Location History:

  • Vedano Al Lambro-Me, IT (1999)
  • Vedan al Lambro, IT (2011)
  • Milan, IT (2004 - 2012)
  • Vedano al Lambro, IT (2000 - 2017)

Company Filing History:


Years Active: 1999-2017

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: The Innovations of Barbara Salom

Introduction

Barbara Salom, an esteemed inventor based in Vedano al Lambro, Italy, has made remarkable contributions to the field of pharmaceuticals with her innovative research. With a total of 11 patents to her name, she has focused primarily on developing compounds that serve as kinase inhibitors, thereby addressing critical health challenges related to dysregulated protein kinase activity.

Latest Patents

Among her latest patents, Barbara Salom has developed a series of compounds known as substituted pyrimidinyl and pyridinyl-pyrrolopyridinones. These compounds modulate the activity of protein kinases and are particularly useful for treating diseases linked to dysregulated protein kinase activity, especially those involving RET family kinases. The invention not only includes methods for preparing these compounds but also outlines pharmaceutical compositions that utilize them for treating relevant diseases.

Another significant patent includes 3,4-dihydro-2H-pyrazino[1,2-A]indol-1-one derivatives, which are recognized for their activity as kinase inhibitors. This invention offers a valuable process for their preparation under Solid Phase Synthesis conditions, along with pharmaceutical compositions comprising these compounds. These derivatives hold potential for treating various conditions, including cancer and autoimmune disorders, significantly contributing to modern medical solutions.

Career Highlights

Barbara's professional journey has seen her collaborate with notable organizations such as Pfizer Italia S.r.l. and Nerviano Medical Sciences S.r.l. Her work in these esteemed companies has allowed her to push the boundaries of pharmaceutical innovation and research. Her 11 patents reflect her dedication and expertise in the challenging field of kinase modulation.

Collaborations

Throughout her career, Barbara has worked alongside talented colleagues, including Matteo D'Anello and Katia Martina. These collaborations have been instrumental in fostering innovation and developing groundbreaking treatments for diseases that significantly impact the global population.

Conclusion

In summary, Barbara Salom is a pioneering inventor whose work on kinase inhibitors is vital for advancements in medical treatment. With her impressive portfolio of patents and collaborations with leading pharmaceutical companies, she embodies the spirit of innovation and dedication necessary to drive progress in the field. Her contributions are sure to leave a lasting impact on the future of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…